Literature DB >> 20703047

Cystoid macular edema in uveitis.

Marc D de Smet, Annabelle A Okada.   

Abstract

Macular edema is a major cause of morbidity in uveitis patients. Inflammatory mediators act on the integrity of the blood ocular barrier and on the function of the RPE pump. Chronicity leads to irreversible changes and is reported to cause up to 30% of permanent visual loss in uveitis patients. Assessing the presence and severity of edema with appropriate investigational techniques (Spectral domain OCT, and angiography) help to determine its reversibility and define a therapeutic strategy wherein intraocular steroids play a key role while RPE pump stimulators and surgery are restricted to more severe disease or the presence of tractional syndromes. 2010 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2010        PMID: 20703047     DOI: 10.1159/000320077

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  9 in total

1.  Intravitreal vascular endothelial growth factor.

Authors:  Thomas Bertelmann; Stephan Schulze; Reka Bölöni; Walter Sekundo; Sebastian Irle; Thomas Stief; Stefan Mennel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-04       Impact factor: 3.117

2.  The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema.

Authors:  Michael A Sandberg; Elizabeth N Pearce; Shyana Harper; Carol Weigel-DiFranco; Lois Hart; Bernard Rosner; Eliot L Berson
Journal:  JAMA Ophthalmol       Date:  2014-10       Impact factor: 7.389

Review 3.  Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema.

Authors:  Omer Karti; Ali Osman Saatci
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

Review 4.  Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis.

Authors:  Vita L S Dingerkus; Marion R Munk; Max P Brinkmann; Florentina J Freiberg; Florian M A Heussen; Stephan Kinzl; Sandra Lortz; Selim Orgül; Matthias Becker
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-05-28

Review 5.  Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors:  Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal:  Clin Ophthalmol       Date:  2019-09-10

6.  Cytoprotective Potential of Fucoxanthin in Oxidative Stress-Induced Age-Related Macular Degeneration and Retinal Pigment Epithelial Cell Senescence In Vivo and In Vitro.

Authors:  Shiu-Jau Chen; Tzer-Bin Lin; Hsien-Yu Peng; Hsiang-Jui Liu; An-Sheng Lee; Cheng-Hsien Lin; Kuang-Wen Tseng
Journal:  Mar Drugs       Date:  2021-02-18       Impact factor: 5.118

7.  A comparison of long-term results after Baerveldt 250 implantation in advanced uveitic vs. other forms of glaucoma.

Authors:  Ioana Maria Cazana; Daniel Böhringer; Thomas Reinhard; Alexandra Anton; Thomas Ness; Jan Lübke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-07       Impact factor: 3.535

8.  Morphological assessment of the retina in uveitis.

Authors:  Michael M Altaweel; Sapna S Gangaputra; Jennifer E Thorne; James P Dunn; Susan G Elner; Glenn J Jaffe; Rosa Y Kim; P Kumar Rao; Susan B Reed; John H Kempen
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-09-09

9.  Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis

Authors:  Murat Hasanreisoğlu; Hüseyin Baran Özdemir; Kaan Özkan; Murat Yüksel; Zeynep Aktaş; Hatice Tuba Atalay; Şengül Özdek; Gökhan Gürelik
Journal:  Turk J Ophthalmol       Date:  2019-10-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.